Client News

Hanryu Holdings’ (NASDAQ:HRYU) Application, FANTOO, Exclusively Markets and Hosts User Voting for Historical Asia Model Festival

New and existing FANTOO users have the opportunity to vote and watch the Asia Model Festival, as it celebrates its 18th year anniversary SEOUL, SOUTH KOREA / ACCESSWIRE / August 16, 2023 / Hanryu Holdings, Inc. (NASDAQ:HRYU) (the “Company” or “Hanryu”), a media-tech company and creator of FANTOO, an all-in-one social media experience connecting K-culture fans globally, […]

Longeveron (NASDAQ: LGVN) to Host Key Opinion Leader Event on Medicinal Signaling Cells (MSCs) for Hypoplastic Left Heart Syndrome (HLHS) with Lomecel-B™ on August 16, 2023

MIAMI, Aug. 14, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced it will host a virtual KOL Event on August 16, 2023 at 10:00 AM ET. Click here to register and attend. The event will feature Sunjay Kaushal, MD, PhD (Northwestern […]

Splash Beverage Group (NYSE American: SBEV) Reports Second Quarter 2023 Financial Results

Quarterly Revenues Rise 15%, Six Month Revenues Rise 31% Quarterly Gross Profit Increase 32% Six Month Gross Profit Increases 34% FORT LAUDERDALE, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today reported financial results for the second quarter period ended June 30, 2023. […]

WiSA Technologies (Nasdaq: WISA) Reports Q2 2023 Results

‘- Five customers that received WiSA E Development Kits represent about 50% of global soundbar market share – – Each customer has potential for over 1 million units per year in volume – BEAVERTON, Ore., August 15, 2023–(BUSINESS WIRE)–WiSA Technologies, Inc. (Nasdaq: WISA), a developer of spatial, wireless sound technology for smart devices and next-generation […]

Tiziana Life Sciences (Nasdaq: TLSA) Announces FDA IND Clearance of Intranasal Foralumab for the Treatment of Alzheimer’s Disease

Foralumab to advance into Phase 2 human clinical trials using the world’s only fully human intranasal anti-CD3 monoclonal antibody Trial to be overseen by Brigham and Women’s Hospital, a founding member of Mass General Brigham Healthcare System NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology […]

Interactive Strength Inc. (Nasdaq: TRNR d/b/a “FORME”) Announces Non-Binding Letter of Intent and Exclusivity Agreement to Acquire a Connected Fitness Equipment Business

The combined Company is projected to generate more than $25 million in gross revenue in 2024 and be cashflow positive and adjusted EBITDA profitable by the fourth quarter of 2024 It is currently anticipated that all of the equity of the target company will be exchanged for TRNR equity and be subject to a “lock-up” until the end of October 2024, similar to pre-IPO shareholders The transaction is expected to close as early […]

Amesite (NASDAQ: AMST) Announces Partnership Renewal with Central Michigan University

DETROIT, Aug. 15, 2023 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces today the renewal of its partnership with the Central Michigan University (CMU). The U.S. Continuing Education market is expected to from USD 60.52 billion in 2022 to an […]

OKYO Pharma (NASDAQ: OKYO) Limited Reports Annual Results for the Twelve Months Ended March 31, 2023

LONDON and NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED”) to address the significant unmet need in this multi-billion-dollar market, today announced financial results for the twelve months ended March 31, 2023 and provided a corporate […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.